The effects of menopause and age on calcitropic hormones: A cross-sectional study of 655 healthy women aged 35 to 90
Open Access
- 1 June 1995
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 10 (6), 835-842
- https://doi.org/10.1002/jbmr.5650100602
Abstract
Although women lose 30% of their skeletal mass after the menopause, the mechanism of this loss is uncertain. Clearly estrogen deficiency is important but whether this works only through direct effects on the skeleton is uncertain. To examine these mechanisms further we have evaluated calcium-related metabolic factors in 655 healthy women. Fasting blood samples were collected from all subjects who were up to 35 years past the menopause, and fasting urine and 24-h urine samples were collected in 365 women who were up to 25 years past the menopause. In the first 15 years postmenopause, there was a rise in total plasma calcium due to a rise in albumin. Bone resorption (hydroxyproline creatinine ratio), bone formation (alkaline phosphatase), and the urine calcium creatinine ratio all rose at menopause and remained elevated for the next 25 years. There was a transient further rise in bone resorption for the 10 years following menopause. Neither PTH nor the free calcitriol index changed for the first 10 years following menopause. Ten years past the menopause, although total calcitriol rose, the free calcitriol index fell due to a rise in vitamin D binding protein. PTH began to rise at 15 years past menopause. GFR fell gradually over the 25 years following menopause. Thus following menopause there is an increase in bone turnover and increased urine calcium loss independent of any effect of PTH or calcitriol, suggesting a direct effect of estrogen deficiency on bone and kidney. At 10 years postmenopause, the free calcitriol index fell and PTH began to rise, these changes being associated with persistent elevation of bone resorption perhaps due to increased PTH action on the bone. The cause of the fall in the free calcitriol ratio may be due to progressive renal deterioration and phosphate retention. The cause of the rise in PTH may be due to a negative external calcium balance due to a reduction in gut calcium absorption, a consequence of relative deficiency of 25 hydroxyvitamin D and the fall in calcitriol together with persistent renal calcium loss.Keywords
Funding Information
- National Health and Medical Research Council
- King Edward Memorial Hospital for Women Research Foundation
- Australian Rotary Health Research Fund
- Sandoz Gerontological Foundation
This publication has 56 references indexed in Scilit:
- Fracture prevalence in an Australian populationAustralian Journal of Public Health, 1993
- Age‐related changes in bone density, serum parathyroid hormone, calcium absorption and other indices of bone metabolism in Chinese womenClinical Endocrinology, 1992
- Identification of estrogen receptor mRNA and the estrogen modulation of parathyroid hormone‐stimulated cyclic AMP accumulation in opossum kidney cellsJournal of Cellular Physiology, 1992
- Effects of estrogen on daylong circulating calcium, phosphorus, 1,25-dihydroxyvitamin d, and parathyroid hormone in postmenopausal womenJournal of Bone and Mineral Research, 1990
- Effects of estrogen on circulating "free" and total 1,25-dihydroxyvitamin D and on the parathyroid-vitamin D axis in postmenopausal women.Journal of Clinical Investigation, 1989
- Estrogen Receptors in Bone in a Patient with Polyostotic Fibrous Dysplasia (McCune-Albright Syndrome)New England Journal of Medicine, 1988
- Calcitriol deficiency with retained synthetic reserve in chronic renal failureKidney International, 1988
- Deficient Production of 1,25-Dihydroxyvitamin D in Elderly Osteoporotic PatientsNew England Journal of Medicine, 1981
- Increases in Immunoreactive Parathyroid Hormone with AgeNew England Journal of Medicine, 1979
- EFFECTS OF NATURAL AND ARTIFICIAL MENOPAUSE ON PLASMA AND URINARY CALCIUM AND PHOSPHORUSThe Lancet, 1967